Charles Henry Rochat

About

Charles Henry Rochat is a leading figure in urologic oncology, with a primary research focus on refining surgical outcomes in robot-assisted radical prostatectomy (RARP). His work is instrumental in understanding how surgical technique directly impacts patient prognosis. A major contribution is his landmark 2013 survey for the European Association of Urology Robotic Urology Section (ERUS), which evaluated surgeon adherence to best practices for RARP, providing a critical baseline assessment that has shaped clinical guidelines (43 citations). Dr. Rochat further advanced the field with a pivotal 2018 study investigating the nuanced relationship between the extent and location of positive surgical margins (PSMs) after robot-assisted laparoscopic prostatectomy (RALP) and the subsequent risk of biochemical recurrence (BCR). This work, which was the first to simultaneously analyze these factors, offers surgeons actionable insights to minimize recurrence risk (19 citations). Through these high-impact studies, Dr. Rochat has significantly enhanced the precision and evidence base of robotic urologic surgery, directly improving long-term outcomes for prostate cancer patients.

Research Focus

Key Achievements

Top Papers

1. 1
   The <scp>E</scp> uropean <scp>A</scp> ssociation of <scp>U</scp> rology <scp>R</scp> obotic <scp>U</scp> rology <scp>S</scp> ection ( <scp>ERUS</scp> ) survey of robot‐assisted radical prostatectomy ( <scp>RARP</scp> )

   43 citations · 2013
2. 2
   Risk of biochemical recurrence based on extent and location of positive surgical margins after robot-assisted laparoscopic radical prostatectomy

   19 citations · 2018

Key Collaborators

Contact & Links